To elucidate the safety and efficacy of exogenous erythropoietin (EPO) for the protection of photoreceptor cells in a rat model of retinal detachment (RD). Intravitreal injection of EPO 400 ng into ...

We have recently shown that intrastriatal injection of recombinant human erythropoietin (EPO) protects dopaminergic (DA) neurons in the substantia nigra (SN) from 6-hydroxydopamine (6-OHDA) toxicity ...

Sportsmen and women have been known to dope with the blood hormone Epo to enhance their performance. Researchers have now discovered, through animal testing, that Epo has a performance-enhancing ...

Injections of an erythropoiesis-stimulating agent (ESA), particularly darbepoetin alfa (Darbe), may eliminate or reduce the need for red blood cell transfusions in preterm infants, according to an ...

The pharmaceutical company Affymax just got $10 million for moving forward with an anemia treatment that would require one injection a month as opposed to as many as several shots a week. Imagine the ...

Surveillance of Patients With Breast Cancer After Curative-Intent Primary Treatment: Current Practice Patterns Information was obtained on patients who received counterfeit erythropoietin, its ...

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...